Re: Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence

Eur Urol. 2024 Jun;85(6):590-591. doi: 10.1016/j.eururo.2024.01.027. Epub 2024 Mar 8.

Authors

Martijn A C Smits¹, John P F A Heesakkers²

Affiliations

¹ Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: [email protected].
² Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands.

PMID: 38461141
DOI: 10.1016/j.eururo.2024.01.027

No abstract available

Publication types

Comment
Letter

MeSH terms

Botulinum Toxins, Type A* / administration & dosage
Botulinum Toxins, Type A* / therapeutic use
Electric Stimulation Therapy / methods
Humans
Lumbosacral Plexus
Neuromuscular Agents / therapeutic use
Time Factors
Treatment Outcome
Urinary Incontinence, Urge* / drug therapy
Urinary Incontinence, Urge* / therapy

Substances

onabotulinum toxin A